TAS-108

· SRI International

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAS-108, covering 2015-08-18 to 2015-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer [Phase 2]